Risk of major adverse cardiovascular events, severe hypoglycemia and all-cause mortality for widely used anti-hyperglycemic dual and triple therapies in type 2 diabetes

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdatosep. 2020
Antal sider1
StatusUdgivet - sep. 2020
Begivenhed56th Annual Meeting of the European Association for the Study of Diabetes (EASD) - Virtual Meeting
Varighed: 21 sep. 202025 sep. 2020

Konference

Konference56th Annual Meeting of the European Association for the Study of Diabetes (EASD)
LokationVirtual Meeting
Periode21/09/202025/09/2020

Citationsformater